Clinical Trial Update: Post-Market Clinical Study of the PanOptix Intraocular Lens (IOL) in a Chinese Population [NA]

View source ↗

Summary

Completed post-market clinical study of the PanOptix intraocular lens in a Chinese population with aphakia and presbyopia; results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aphakia
• Presbyopia

Drugs mentioned

• PanOptix intraocular lens (intraocular lens)

Snippet

Sponsor: Alcon Research | Conditions: Aphakia, Presbyopia | NA | Status: COMPLETED | Results posted: 2023-10-10